Carregando...
Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation
Atrial fibrillation is the most common cause of stroke. Treatment with anticoagulants in patients with atrial fibrillation reduces embolic complications of the disease including stroke. However, the commonly used anticoagulant has a narrow therapeutic index, requires routine monitoring, and has nume...
Na minha lista:
| Publicado no: | Ther Adv Cardiovasc Dis |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933600/ https://ncbi.nlm.nih.gov/pubmed/26378211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944715605011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|